Healius Limited Stock Price

ASX:HLS Community·AU$682.6m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
28 Fair Values set on narratives written by author

Create a narrative

HLS Share Price Performance

AU$0.94

-0.38 (-28.52%)

AU$0.94

-0.38 (-28.52%)

AU$0.94

Fri, 21 Nov 25

Share Pricen/a

HLS Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Undervalued with adequate balance sheet.

0 Risks

3 Rewards

View Full Analysis

Healius Limited Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.78
: 29.65%
: -41.88%
: 0%

View Full Analysis

About HLS

Founded: 1994
Employees: 5962
CEO: Paul Anderson
WebsiteView website: www.healius.com.au

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.